0001209191-20-037020.txt : 20200616 0001209191-20-037020.hdr.sgml : 20200616 20200616172932 ACCESSION NUMBER: 0001209191-20-037020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200610 FILED AS OF DATE: 20200616 DATE AS OF CHANGE: 20200616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WORLAND STEPHEN T CENTRAL INDEX KEY: 0001283307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36818 FILM NUMBER: 20967404 MAIL ADDRESS: STREET 1: 9050 CAMINO SANTA FE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001394319 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 BUSINESS PHONE: 858-550-0780 MAIL ADDRESS: STREET 1: 4350 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 800 CITY: San Diego STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc DATE OF NAME CHANGE: 20070324 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-10 0 0001394319 Tracon Pharmaceuticals, Inc. TCON 0001283307 WORLAND STEPHEN T 4350 LA JOLLA VILLAGE DRIVE SUITE 800 SAN DIEGO CA 92122 1 0 0 0 Director Stock Option (Right to Buy) 2.07 2020-06-10 4 A 0 4500 0.00 A 2030-06-09 Common Stock 4500 4500 D The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders. /s/ Scott B. Brown, Attorney-In-Fact 2020-06-15